NeuroPace Inc (NPCE)
13.40
-0.10
(-0.74%)
USD |
NASDAQ |
Apr 15, 16:00
13.33
-0.07
(-0.52%)
Pre-Market: 20:00
NeuroPace Shareholders Equity (Quarterly): 20.65M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.65M |
| September 30, 2023 | 16.36M |
| June 30, 2023 | 21.23M |
| March 31, 2023 | 27.49M |
| December 31, 2022 | 34.78M |
| September 30, 2022 | 43.41M |
| June 30, 2022 | 52.90M |
| Date | Value |
|---|---|
| March 31, 2022 | 62.82M |
| December 31, 2021 | 73.50M |
| September 30, 2021 | 81.71M |
| June 30, 2021 | 88.67M |
| March 31, 2021 | -156.44M |
| December 31, 2020 | -147.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-156.44M
Minimum
Mar 2021
88.67M
Maximum
Jun 2021
16.87M
Average
34.78M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Ainos Inc | 24.45M |
| OpGen Inc | 2.677M |
| Zomedica Corp | 240.02M |
| LENSAR Inc | 33.43M |
| Eargo Inc (DELISTED) | 45.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.65M |
| Total Liabilities (Quarterly) | 87.00M |
| Debt to Equity Ratio | 2.758 |
| Current Ratio | 5.713 |
| Net Debt Paydown Yield | -0.35% |